Galectin-7 as a Biomarker for Esophageal Squamous Cell Carcinoma
Author Information
Author(s): Zhu Xi, Ding Ming, Yu Mei-Lan, Feng Ming-Xiang, Tan Li-Jie, Zhao Fu-Kun
Primary Institution: Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
Hypothesis
Can galectin-7 serve as a potential biomarker for esophageal squamous cell carcinoma (ESCC)?
Conclusion
Galectin-7 is highly expressed in ESCC tissues and could be used as a potential biomarker for the disease.
Supporting Evidence
- Galectin-7 was confirmed to be up-regulated in ESCC samples compared to normal tissues.
- Immunohistochemical staining showed higher levels of galectin-7 in ESCC tissues.
- Expression levels of galectin-7 were related to the differentiation of ESCC.
Takeaway
Researchers found that a protein called galectin-7 is much more present in cancerous esophagus tissues than in normal ones, which might help doctors detect this type of cancer earlier.
Methodology
The study used proteomic analysis, including two-dimensional gel electrophoresis and mass spectrometry, to compare protein expression in ESCC and normal tissues.
Participant Demographics
10 patients with esophageal squamous cell carcinoma, including a mix of genders and ages ranging from 52 to 70.
Statistical Information
P-Value
0.012
Statistical Significance
p=0.012
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website